Transient receptor potential vanilloid 1 plays a major role in low temperature-mediated skin barrier dysfunction

被引:11
作者
Kim, Byung Eui [1 ]
Hui-Beckman, Jessica [1 ]
Lyubchenko, Taras [1 ,2 ]
Hall, Clifton F. [1 ]
Fallahi, Sahand [1 ,2 ]
Brull, Amelia [1 ]
Goleva, Elena [1 ]
Leung, Donald Y. M. [1 ,3 ]
机构
[1] Natl Jewish Hlth, Dept Pediat, Denver, CO USA
[2] Univ Denver, Dept Biol Sci, Denver, CO USA
[3] Natl Jewish Hlth, 1400 Jackson St,K801a, Denver, CO 80206 USA
关键词
Low temperature; filaggrin; TRPV1; TSLP; skin barrier; organotypic skin culture; DOWN-REGULATES FILAGGRIN; ATOPIC-DERMATITIS; CYTOKINE MODULATION; CLIMATE-CHANGE; COLD-EXPOSURE; TRP CHANNELS; RISK-FACTORS; ACTIVATION; EXPRESSION; HEALTH;
D O I
10.1016/j.jaci.2022.01.027
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Children born in the fall and winter are at increased risk for developing atopic dermatitis and food allergy. Because these seasons are associated with low temperatures, we hypothesized that exposure to low temperatures may compromise keratinocyte differentiation and contribute to skin barrier dysfunction. Objective: We examined whether low temperature causes skin barrier dysfunction. Methods: Primary human epidermal keratinocytes (HEK) were differentiated in 1.3 mmol CaCl2 media and cultured at different temperatures. The cells were transfected with transient receptor potential cation channel subfamily V member 1 (TRPV1) or STAT3 small interfering RNA (siRNA) to examine the effects of these gene targets in HEK exposed to low temperature. Gene expression of TRPV1, epidermal barrier proteins, and keratinocyte-derived cytokines were evaluated. Organotypic skin equivalents were generated using HEK transfected with control or TRPV1 siRNA and grown at 25 degrees C or 37 degrees C. Transepidermal water loss (TEWL) and levels of epidermal barrier proteins were evaluated. Results: Filaggrin (FLG) and loricrin (LOR) expression, but not keratin (KRT)-1 and KRT-10 expression, was downregulated in HEK incubated at 25 degrees C, while TRPV1 silencing increased intracellular Ca2+ influx (keratinocyte differentiation signal) and enhanced the expression of epidermal differentiation proteins. IL-1 beta and thymic stromal lymphopoietin induced by low temperature inhibited FLG expression in keratinocytes through the TRPV1/STAT3 pathway. Moreover, low temperature-mediated inhibition of FLG and LOR was recovered, and TEWL was decreased in organotypic skin transfected with TRPV1 siRNA. Conclusion: TRPV1 is critical in low temperature-mediated skin barrier dysfunction. Low temperature exposure induced thymic stromal lymphopoietin, an alarmin implicated in epicutaneous allergen sensitization.
引用
收藏
页码:362 / +
页数:18
相关论文
共 50 条
  • [21] Transient Receptor Potential Vanilloid Subtype 1: Potential Role in Infection, Susceptibility, Symptoms and Treatment of COVID-19
    Liviero, Filippo
    Campisi, Manuela
    Mason, Paola
    Pavanello, Sofia
    FRONTIERS IN MEDICINE, 2021, 8
  • [22] Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1
    Ching, Li-Chieh
    Kou, Yu Ru
    Shyue, Song-Kun
    Su, Kuo-Hui
    Wei, Jeng
    Cheng, Li-Ching
    Yu, Yuan-Bin
    Pan, Ching-Chian
    Lee, Tzong-Shyuan
    CARDIOVASCULAR RESEARCH, 2011, 91 (03) : 492 - 501
  • [23] THE ROLE OF TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 RECEPTOR IN DESIPRAMINE INDUCED ANALGESIC EFFECT IN DIABETIC MICE
    Shaikh, Sana
    Deshpande, Shrikalp
    Gohil, Priyanshee
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (12): : 4882 - 4887
  • [24] Aging reverses the role of the transient receptor potential vanilloid-1 channel in systemic inflammation from anti-inflammatory to proinflammatory
    Wanner, Samuel P.
    Garami, Andras
    Pakai, Eszter
    Oliveira, Daniela L.
    Gavva, Narender R.
    Coimbra, Candido C.
    Romanovsky, Andrej A.
    CELL CYCLE, 2012, 11 (02) : 343 - 349
  • [25] Molecular and Functional Study of Transient Receptor Potential Vanilloid 1-4 at the Rat and Human Blood-Brain Barrier Reveals Interspecies Differences
    Luo, Huilong
    Saubamea, Bruno
    Chasseigneaux, Stephanie
    Cochois, Veronique
    Smirnova, Maria
    Glacial, Fabienne
    Perriere, Nicolas
    Chaves, Catarina
    Cisternino, Salvatore
    Decleves, Xavier
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [26] The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature
    Alawi, Khadija M.
    Aubdool, Aisah A.
    Liang, Lihuan
    Wilde, Elena
    Vepa, Abhinav
    Psefteli, Maria-Paraskevi
    Brain, Susan D.
    Keeble, Julie E.
    FASEB JOURNAL, 2015, 29 (10) : 4285 - 4298
  • [27] Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms
    Ehnis-Perez, Adriana
    Torres-Alvarez, Bertha
    Cortes-Garcia, Diego
    Hernandez-Blanco, Diana
    Fuentes-Ahumada, Cornelia
    Pablo Castanedo-Cazares, Juan
    JOURNAL OF COSMETIC DERMATOLOGY, 2016, 15 (03) : 231 - 237
  • [28] Ameliorating Endothelial Mitochondrial Dysfunction Restores Coronary Function via Transient Receptor Potential Vanilloid 1-Mediated Protein Kinase A/Uncoupling Protein 2 Pathway
    Xiong, Shiqiang
    Wang, Peijian
    Ma, Liqun
    Gao, Peng
    Gong, Liuping
    Li, Li
    Li, Qiang
    Sun, Fang
    Zhou, Xunmei
    He, Hongbo
    Chen, Jing
    Yan, Zhencheng
    Liu, Daoyan
    Zhu, Zhiming
    HYPERTENSION, 2016, 67 (02) : 451 - 460
  • [29] Evodiamine Induces Transient Receptor Potential Vanilloid-1-Mediated Protective Autophagy in U87-MG Astrocytes
    Liu, Ann-Jeng
    Wang, Sheng-Hao
    Hou, Sz-Ying
    Lin, Chien-Ju
    Chiu, Wen-Ta
    Hsiao, Sheng-Huang
    Chen, Thay-Hsiung
    Shih, Chwen-Ming
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [30] Transient Receptor Potential Vanilloid1 (TRPV1) Channel Opens Sesame of T Cell Responses and T Cell-Mediated Inflammatory Diseases
    Xiao, Tengfei
    Sun, Mingzhong
    Kang, Jingjing
    Zhao, Chuanxiang
    FRONTIERS IN IMMUNOLOGY, 2022, 13